165 related articles for article (PubMed ID: 34356062)
1. Select Porcine Elongation Factor 1α Sequences Mediate Stable High-Level and Upregulated Expression of Heterologous Genes in Porcine Cells in Response to Primate Serum.
Sun WS; Yang H; No JG; Lee H; Lee N; Lee M; Kang MJ; Oh KB
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356062
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive evaluation of ubiquitous promoters suitable for the generation of transgenic cynomolgus monkeys†.
Seita Y; Tsukiyama T; Azami T; Kobayashi K; Iwatani C; Tsuchiya H; Nakaya M; Tanabe H; Hitoshi S; Miyoshi H; Nakamura S; Kawauchi A; Ema M
Biol Reprod; 2019 Jun; 100(6):1440-1452. PubMed ID: 30869744
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activities of human elongation factor-1α and cytomegalovirus promoter in transgenic dogs generated by somatic cell nuclear transfer.
Eun K; Hong N; Jeong YW; Park MG; Hwang SU; Jeong YIK; Choi EJ; Olsson PO; Hwang WS; Hyun SH; Kim H
PLoS One; 2020; 15(6):e0233784. PubMed ID: 32492024
[TBL] [Abstract][Full Text] [Related]
4. The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells.
Wang X; Xu Z; Tian Z; Zhang X; Xu D; Li Q; Zhang J; Wang T
J Cell Mol Med; 2017 Nov; 21(11):3044-3054. PubMed ID: 28557288
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of promoters for driving efficient transgene expression in neonatal porcine islets.
Londrigan SL; Brady JL; Sutherland RM; Hawthorne WJ; Thomas HE; Jhala G; Cowan PJ; Kay TW; O'Connell PJ; Lew AM
Xenotransplantation; 2007 Mar; 14(2):119-25. PubMed ID: 17381686
[TBL] [Abstract][Full Text] [Related]
6. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner.
Xia X; Zhang Y; Zieth CR; Zhang SC
Stem Cells Dev; 2007 Feb; 16(1):167-76. PubMed ID: 17348812
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-inducible promoters to drive dynamic transgene expression: The "Smart Graft" strategy.
Fischer A; Manske K; Seissler J; Wohlleber D; Simm N; Wolf-van Buerck L; Knolle P; Schnieke A; Fischer K
Xenotransplantation; 2020 Nov; 27(6):e12634. PubMed ID: 32808410
[TBL] [Abstract][Full Text] [Related]
8. Human TNF-related apoptosis-inducing ligand-expressing dendritic cells from transgenic pigs attenuate human xenogeneic T cell responses.
Kemter E; Lieke T; Kessler B; Kurome M; Wuensch A; Summerfield A; Ayares D; Nagashima H; Baars W; Schwinzer R; Wolf E
Xenotransplantation; 2012; 19(1):40-51. PubMed ID: 22360752
[TBL] [Abstract][Full Text] [Related]
9. New function of a well-known promoter: Enhancer activity of minimal CMV promoter enables efficient dual-cassette transgene expression.
Boateng-Antwi MKA; Lin Y; Ren S; Wang X; Pan D
J Gene Med; 2021 Nov; 23(11):e3380. PubMed ID: 34318559
[TBL] [Abstract][Full Text] [Related]
10. Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter.
Duan B; Cheng L; Gao Y; Yin FX; Su GH; Shen QY; Liu K; Hu X; Liu X; Li GP
Theriogenology; 2012 Sep; 78(4):793-802. PubMed ID: 22541322
[TBL] [Abstract][Full Text] [Related]
11. The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors.
Alexopoulou AN; Couchman JR; Whiteford JR
BMC Cell Biol; 2008 Jan; 9():2. PubMed ID: 18190688
[TBL] [Abstract][Full Text] [Related]
12. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
[TBL] [Abstract][Full Text] [Related]
13. The in vitro activity and specificity of human endothelial cell-specific promoters in porcine cells.
He Z; She R; Sumitran-Holgersson S; Blomberg P; Islam KB; Holgersson J
Xenotransplantation; 2001 Aug; 8(3):202-12. PubMed ID: 11472628
[TBL] [Abstract][Full Text] [Related]
14. Identification of the Porcine Vascular Endothelial Cell-Specific Promoter ESAM1.0 Using Transcriptome Analysis.
Kim SE; Sun WS; Oh M; Lee S; No JG; Lee H; Lee P; Oh KB
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895277
[TBL] [Abstract][Full Text] [Related]
15. Transgenic pigs for xenotransplantation: selection of promoter sequences for reliable transgene expression.
Aigner B; Klymiuk N; Wolf E
Curr Opin Organ Transplant; 2010 Apr; 15(2):201-6. PubMed ID: 20061949
[TBL] [Abstract][Full Text] [Related]
16. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice.
Xu L; Daly T; Gao C; Flotte TR; Song S; Byrne BJ; Sands MS; Parker Ponder K
Hum Gene Ther; 2001 Mar; 12(5):563-73. PubMed ID: 11268288
[TBL] [Abstract][Full Text] [Related]
17. Cloning and expression of porcine β1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen.
Byrne GW; Du Z; Stalboerger P; Kogelberg H; McGregor CG
Xenotransplantation; 2014; 21(6):543-54. PubMed ID: 25176027
[TBL] [Abstract][Full Text] [Related]
18. Strong, long-term transgene expression in rat liver using chicken beta-actin promoter associated with cytomegalovirus immediate-early enhancer (CAG promoter).
Kosuga M; Enosawa S; Li XK; Suzuki S; Matsuo N; Yamada M; Roy-Chowdhury J; Koiwai O; Okuyama T
Cell Transplant; 2000; 9(5):675-80. PubMed ID: 11144964
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells.
Ebadat S; Ahmadi S; Ahmadi M; Nematpour F; Barkhordari F; Mahdian R; Davami F; Mahboudi F
PLoS One; 2017; 12(10):e0185967. PubMed ID: 29023479
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
Teschendorf C; Warrington KH; Siemann DW; Muzyczka N
Anticancer Res; 2002; 22(6A):3325-30. PubMed ID: 12530082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]